Shmuel Bukshpan

This inventor holds 14 USPTO granted patents and 14 published patent applications and 3 EPO patents. Top assignees: Minovia Therapeutics Ltd., Protein Forest, Inc., Cellect Technologies Corp.. Active years: 2003-2026.

USPTO Granted Patents = 14 (Patent Applications = 14)

% Patents Active = 64.3

EPO Patents = 3 (Patent Applications = 10)

Average Co-Inventor Count = 2.2

ph-index = 6

Forward Citations = 218(Granted Patents)

Company Filing History:

7 out of 12

Minovia Therapeutics Ltd.

Cellect Technologies Corp.

patent

4. 1 out of 1

Sonata Technologies Ltd.

patent

5. 3 out of 834,411

Other

patents

Years Active: 2003-2026

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12551504 - Mitochondrial augmentation therapy of pancreatic diseases (2026-02-17),

2. 12502408 - Mitochondrial augmentation therapy for primary mitochondrial diseases (2025-12-23),

3. 12440515 - Mitochondrial augmentation therapy of brain diseases (2025-10-14),

4. 12329781 - Mitochondrial augmentation therapy of renal diseases (2025-06-17),

5. 12239672 - Mitochondrial augmentation therapy of ocular diseases (2025-03-04),

6. 11951135 - Mitochondrial augmentation therapy of muscle diseases (2024-04-09),

7. 10702556 - Compositions and methods for inducing angiogenesis (2020-07-07),

8. 10325379 - Sweat pores imaging method and device (2019-06-18),

9. 8038792 - Methods and apparatus for rapid crystallization of biomolecules (2011-10-18),

10. 7914656 - Matrixes, arrays, systems and methods (2011-03-29),

11. 7459021 - Methods and apparatus for rapid crystallization of biomolecules (2008-12-02),

12. 7354733 - Method for sorting and separating living cells (2008-04-08),

13. 7166202 - Matrixes, arrays, systems and methods (2007-01-23),

14. 6514203 - Method for ultrasonic coronary thrombolysis (2003-02-04),

Title: Shmuel Bukshpan: Innovator in Mitochondrial Augmentation Therapy

Introduction

Shmuel Bukshpan is a prominent inventor based in Ramat Hasharon, Israel. He has made significant contributions to the field of mitochondrial augmentation therapy, focusing on treatments for brain and renal diseases. With a total of 14 patents to his name, Bukshpan's work is paving the way for innovative therapeutic approaches.

Latest Patents

Among his latest patents, Bukshpan has developed groundbreaking methods for treating brain diseases through mitochondrial augmentation therapy. His invention provides stem cells enriched with healthy functional mitochondria, along with pharmaceutical compositions that utilize these cells. This therapy aims to address brain diseases, disorders, and symptoms, regardless of whether they are associated with acquired mitochondrial dysfunction. Additionally, he has created a similar therapeutic approach for renal diseases, offering new hope for patients suffering from these conditions.

Career Highlights

Shmuel Bukshpan has worked with Minovia Therapeutics Ltd., where he has been instrumental in advancing research and development in mitochondrial therapies. His expertise and innovative mindset have positioned him as a key figure in this emerging field.

Collaborations

Bukshpan has collaborated with notable professionals in his field, including Uriel Halavee and Natalie Yivgi Ohana. These partnerships have further enhanced his research and contributed to the success of his inventions.

Conclusion

Shmuel Bukshpan's work in mitochondrial augmentation therapy represents a significant advancement in medical science. His innovative patents and collaborations are set to make a lasting impact on the treatment of brain and renal diseases.